Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Latest reported RXRX revenue for 2026-06-30 was $14.1M. Net income was -$248.5M. RXRX currently screens at market cap $1.75B.
Use this RXRX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the RXRX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the RXRX SEC filings page. Lician reads the product cache first so this HTML stays unique to Recursion Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full RXRX income, balance, and cash tables.